SMALL CELL LUNG CANCER EXTENSIVE STAGE
Clinical trials for SMALL CELL LUNG CANCER EXTENSIVE STAGE explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER EXTENSIVE STAGE trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER EXTENSIVE STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple therapy may extend life in aggressive lung cancer
Disease control Recruiting nowThis study tests whether adding an immunotherapy drug (adebrelimab) and low-dose radiation to standard chemotherapy can help people with extensive-stage small cell lung cancer live longer. About 202 adults aged 18-75 who have not had prior treatment for this stage will take part.…
Matched conditions: SMALL CELL LUNG CANCER EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated May 17, 2026 10:45 UTC
-
Gene therapy duo takes on tough lung cancer
Disease control Recruiting nowThis study tests a new gene therapy (quaratusugene ozeplasmid) combined with an immunotherapy drug (atezolizumab) as maintenance treatment for people with extensive-stage small cell lung cancer. The goal is to see if this combination can keep the cancer from growing longer than s…
Matched conditions: SMALL CELL LUNG CANCER EXTENSIVE STAGE
Phase: PHASE1, PHASE2 • Sponsor: Genprex, Inc. • Aim: Disease control
Last updated May 17, 2026 10:38 UTC
-
New hope for tough lung cancer: two experimental drugs join forces
Disease control Recruiting nowThis study tests two new medicines, gocatamig and I-DXd, alone or with standard treatment, for people with extensive-stage small cell lung cancer (cancer that has spread). The goal is to see if the combination is safe and helps shrink or control the cancer. About 170 adults will …
Matched conditions: SMALL CELL LUNG CANCER EXTENSIVE STAGE
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Tailored radiation: a new hope for cancer patients?
Disease control Recruiting nowThis early-stage trial tests whether customizing radiotherapy based on how a person's tumor responds can improve safety and effectiveness. It involves 45 adults with certain lung cancers, brain metastases, or solid tumors. The goal is to see if adapting radiation doses can better…
Matched conditions: SMALL CELL LUNG CANCER EXTENSIVE STAGE
Phase: PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated May 15, 2026 11:55 UTC